Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer is a research paper published in Urologic Oncology Seminars and Original Investigations (2020). On theSindex it has a DataRank of 0. It has been cited 41 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 141466
Bayer Fund
Bayer HealthCare
GlaxoSmithKline
GlaxoSmithKline Australia
Bayer
FWCI
2.43
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals